PJ-020

N/A

Report date: 2026/04/22 20:01:10

Base Information

Drug NamePJ-020
Drug Alias Name注射用重组酰化胰高血糖素样肽2类似物
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 2 receptor agonists
TargetsGlucagon-like peptide 2 receptor
Therapy Area/IndicationsDiarrheaShort Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChongqing Peg-Bio Biopharm Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesChongqing Peg-Bio Biopharm Co Ltd
Inactive CompaniesN/A
Active IndicationsDiarrheaShort Bowel Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A